GenoMed Inc. (GMED)

[mingwan0]

St Louis Business Journal article

This one doesn't add anything to what was in the press release. I note that Dr Moskowitz said this will allow the company to "move forward with its scientific program and its marketing strategy to physicians and patients nationwide." There is no reference to the Malaysian partnership here.

http://stlouis.bizjournals.com/stlouis/stories/2004/03/01/daily41.html?jst=b_ln_hl

GenoMed gets long-term financing commitment
Pierpoint Investissements SA, a Swiss-based venture capital group, has agreed to provide long-term finding to St. Louis-based GenoMed Inc., the company said Wednesday.

Pierpoint will make a minimum annual investment of $500,000 up to a maximum of $2 million a year for each of the next 10 years in exchange for 12-month restricted shares at a discount to market price. Pierpoint will also hold active warrants for another 35 million shares, which can be converted only when GenoMed's stock price reaches at least $1, at a rate of 7 million warrants a year.

Dr. David Moskowitz, chief medical and chief executive of GenoMed, said the financing allows the company to move forward with its scientific program and its marketing strategy to physicians and patients nationwide.

St. Louis-based GenoMed Inc. (Pink Sheets: GMED) is a medical genomics company working to find genes that cause disease. The company's shares closed March 2 at 12.3 cents.